Sequence information
Variant position: 379 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 437 The length of the canonical sequence.
Location on the sequence:
SGGGLSTKMSIQGCVAQPSS
F LLNHTRQIGIFSAREKRDVQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human SGGGLSTKMSIQGCVAQPSSF LLNHTRQIGIFSAREKRDVQ
Mouse QGGGLTTRVSIQGCMAPPIKP LLGDSKTIGIFSAEESSNYR
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
22 – 408
CD177 antigen
Alternative sequence
146 – 437
Missing. In isoform 3.
Alternative sequence
249 – 437
Missing. In isoform 2.
Literature citations
Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immunenneutropenia and transfusion reactions.
Kissel K.; Santoso S.; Hofmann C.; Stroncek D.; Bux J.;
Eur. J. Immunol. 31:1301-1309(2001)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); PROTEIN SEQUENCE OF 35-45; 167-175 AND 386-393; VARIANTS PRO-3; PHE-119; ILE-251; GLN-323 AND SER-379; MASS SPECTROMETRY; GLYCOSYLATION;
CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression.
Caruccio L.; Walkovich K.; Bettinotti M.; Schuller R.; Stroncek D.;
Transfusion 44:77-82(2004)
Cited for: VARIANTS PRO-3; PHE-119; GLN-323 AND SER-379; POLYMORPHISM;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.